Literature DB >> 24661192

Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.

Emily Reeve1, Sepehr Shakib, Ivanka Hendrix, Michael S Roberts, Michael D Wiese.   

Abstract

Inappropriate use of medication is widespread, especially in older people, and is associated with risks, including adverse drug reactions, hospitalization and increased mortality. Optimization of appropriate medication use to minimize these harms is an ongoing challenge in healthcare. The term 'deprescribing' has been used to describe the complex process that is required for safe and effective cessation of medication. Patients play an important role in their own health and, while they may complain about the number of medications they have to take, they may also be reluctant to cease a medication when given the opportunity to do so. A review of previously proposed deprescribing processes and relevant literature was used to develop the patient-centred deprescribing process, which is a five-step cycle that encompasses gaining a comprehensive medication history, identifying potentially inappropriate medications, determining whether the potentially inappropriate medication can be ceased, planning the withdrawal regimen (e.g. tapering where necessary) and provision of monitoring, support and documentation. This is the first deprescribing process developed using knowledge of the patients' views of medication cessation; it focuses on engaging patients throughout the process, with the aim of improving long-term health outcomes. Despite a comprehensive review of the literature, there is still a lack in the evidence base on which to conduct deprescribing. The next step in broadening the evidence to support deprescribing will be to test the developed process to determine feasibility in the clinical setting.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  deprescribing; deprescribing process; elderly; inappropriate medication use; medication withdrawal; polypharmacy

Mesh:

Year:  2014        PMID: 24661192      PMCID: PMC4239968          DOI: 10.1111/bcp.12386

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  83 in total

1.  Discontinuation of unnecessary medications in older adults.

Authors:  Nicole J Brandt; Richard G Stefanacci
Journal:  Consult Pharm       Date:  2011-11

Review 2.  Clinical practice. Preventing falls in elderly persons.

Authors:  Mary E Tinetti
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

3.  People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe.

Authors:  Emily Reeve; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib
Journal:  J Am Geriatr Soc       Date:  2013-08-26       Impact factor: 5.562

4.  Reconsidering medication appropriateness for patients late in life.

Authors:  Holly M Holmes; Déon Cox Hayley; G Caleb Alexander; Greg A Sachs
Journal:  Arch Intern Med       Date:  2006-03-27

5.  Reducing medication regimen complexity for older patients prior to discharge from hospital: feasibility and barriers.

Authors:  R A Elliott
Journal:  J Clin Pharm Ther       Date:  2012-05-21       Impact factor: 2.512

6.  The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old.

Authors:  Inga Klarin; Anders Wimo; Johan Fastbom
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners.

Authors:  A S Raghunath; A P S Hungin; C S Cornford; V Featherstone
Journal:  Digestion       Date:  2005-11-11       Impact factor: 3.216

8.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

9.  The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people.

Authors:  Mark E Williams; Charles C Pulliam; Rebecca Hunter; Ted M Johnson; Justine E Owens; Jean Kincaid; Carol Porter; Gary Koch
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

10.  The experience of discontinuing antiepileptic drug treatment: an exploratory investigation.

Authors:  S Kilinç; C Campbell
Journal:  Seizure       Date:  2008-03-10       Impact factor: 3.184

View more
  80 in total

1.  GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.

Authors:  Hélène Carrier; Anna Zaytseva; Aurélie Bocquier; Patrick Villani; Hélène Verdoux; Martin Fortin; Pierre Verger
Journal:  Br J Gen Pract       Date:  2019-02-25       Impact factor: 5.386

Review 2.  Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies.

Authors:  Beate Bokhof; Ulrike Junius-Walker
Journal:  Drugs Aging       Date:  2016-04       Impact factor: 3.923

3.  Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Authors:  Katie Qi; Emily Reeve; Sarah N Hilmer; Sallie-Anne Pearson; Slade Matthews; Danijela Gnjidic
Journal:  Int J Clin Pharm       Date:  2015-06-06

4.  Deprescribing in palliative care.

Authors:  Jo Thompson
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

5.  Tapering or abrupt cessation of proton pump inhibitors?

Authors:  Emily Reeve; Sarah Hilmer
Journal:  Eur J Clin Pharmacol       Date:  2017-03-22       Impact factor: 2.953

6.  Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study.

Authors:  Luca Pasina; Barbara Brignolo Ottolini; Laura Cortesi; Mauro Tettamanti; Carlotta Franchi; Alessandra Marengoni; Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Med Princ Pract       Date:  2019-03-20       Impact factor: 1.927

7.  The role of the OncPal deprescribing guideline in end-of-life care.

Authors:  Emily Reeve; Danijela Gnjidic; Sarah Hilmer
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

8.  Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.

Authors:  Hélène Carrier; Sébastien Cortaredona; Viviane Philipps; Hélène Jacqmin-Gadda; Marie Tournier; Hélène Verdoux; Pierre Verger
Journal:  Br J Clin Pharmacol       Date:  2020-05-10       Impact factor: 4.335

9.  Effectiveness of an intervention to optimise the use of mirabegron for overactive bladder: a quasi-experimental study in primary care.

Authors:  Eladio Fernández-Liz; Pere Vivó Tristante; Antonio Aranzana Martínez; Maria Estrella Barceló Colomer; Josep Ossó Rebull; Maria Josep López Dolcet
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

10.  Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.

Authors:  Alessandro Galazzi; Maura Lusignani; Maria Teresa Chiarelli; Pier Mannuccio Mannucci; Carlotta Franchi; Mauro Tettamanti; Emily Reeve; Alessandro Nobili
Journal:  Int J Clin Pharm       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.